Targeted MRM-analysis of plasma proteins in frozen whole blood samples from patients with COVID-19: a retrospective study

Objectives: The COVID-19 pandemic has exposed a number of key challenges that need to be urgently addressed. Mass spectrometric studies of blood plasma proteomics provide a deep understanding of the relationship between the severe course of infection and activation of specific pathophysiological pathways. Analysis of plasma proteins in whole blood may also be relevant for the pandemic as it requires minimal sample preparation. Methods: The frozen whole blood samples were used to analyze 203 plasma proteins using multiple reaction monitoring (MRM) mass spectrometry and stable isotope-labeled peptide standards (SIS). A total of 131 samples (FRCC, Russia) from patients with mild (n=41), moderate (n=39) and severe (n=19) COVID-19 infection and healthy controls (n=32) were analyzed. Results: Levels of 94 proteins were quantified and compared. Significant differences between all of the groups were revealed for 44 proteins. Changes in the levels of 61 reproducible COVID-19 markers (SERPINA3, SERPING1, ORM1, HRG, LBP, APOA1, AHSG, AFM, ITIH2, etc.) were consistent with studies performed with serum/plasma samples. The best-performing classifier built with 10 proteins achieved the best combination of ROC-AUC (0.97–0.98) and accuracy (0.90–0.93) metrics and distinguished patients from controls, as well as patients by severity. Conclusions: Here, for the first time, frozen whole blood samples were used for proteomic analysis and assessment of the status of patients with COVID-19. The results obtained with frozen whole blood samples are consistent with those from plasma and serum.

Angaben zum Objekt

• Standort: Deutsche Nationalbibliothek Frankfurt am Main
• Umfang: Online-Ressource
• Sprache: Englisch

Verweise und Beziehungen

• Erschienen in: Targeted MRM-analysis of plasma proteins in frozen whole blood samples from patients with COVID-19: a retrospective study ; volume:63 ; number:2 ; year:2025 ; pages:448-457 ; extent:10 ; Clinical chemistry and laboratory medicine ; 63, Heft 2 (2025), 448-457 (gesamt 10)

Beteiligte, Orts- und Zeitangaben

• Urheber: Bugrova, Anna E. ; Strelnikova, Polina A. ; Kononikhin, Alexey S. ; Zakharova, Natalia V. ; Diyachkova, Elizaveta O. ; Brzhozovskiy, Alexander G. ; Indeykina, Maria I. ; Kurochkin, Ilya N. ; Averyanov, Alexander V. ; Nikolaev, Evgeny N.

Weitere Informationen

• DOI: 10.1515/cclm-2024-0800
• URN: urn:nbn:de:101:1-2412301445306.145920589413
• Rechteinformation: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
• Letzte Aktualisierung: 15.08.2025, 07:39 MESZ